Next Article in Journal
Micropulse Laser Treatment of Retinal Diseases
Previous Article in Journal
Carbon Fiber Reinforced PEEK Composites Based on 3D-Printing Technology for Orthopedic and Dental Applications
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
JCM
Volume 8
Issue 2
10.3390/jcm8020241
jcm-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Brief Report

Cell-Free DNA and CXCL10 Derived from Bronchoalveolar Lavage Predict Lung Transplant Survival

by
Joshua Y.C. Yang
1,2,
Stijn E. Verleden
3,
Arya Zarinsefat
1,
Bart M. Vanaudenaerde
3,
Robin Vos
3,
Geert M. Verleden
3,
Reuben D. Sarwal
1,
Tara K. Sigdel
1,
Juliane M. Liberto
1,
Izabella Damm
1,
Drew Watson
2 and
Minnie M. Sarwal
1,2,*
1
Department of Surgery, University of California San Francisco, San Francisco, CA 94143, USA
2
KIT Bio, 2000 University Avenue, Palo Alto, CA 94303, USA
3
Leuven Lung Transplant Unit, Department of Chronic Diseases, Metabolism, and Ageing (CHROMETA), KU Leuven, 3000 Leuven, Belgium
*
Author to whom correspondence should be addressed.
J. Clin. Med. 2019, 8(2), 241; https://doi.org/10.3390/jcm8020241
Submission received: 17 January 2019 / Revised: 5 February 2019 / Accepted: 8 February 2019 / Published: 13 February 2019
(This article belongs to the Section Respiratory Medicine)
Browse Figures
Versions Notes

Abstract

Standard methods for detecting chronic lung allograft dysfunction (CLAD) and rejection have poor sensitivity and specificity and have conventionally required bronchoscopies and biopsies. Plasma cell-free DNA (cfDNA) has been shown to be increased in various types of allograft injury in transplant recipients and CXCL10 has been reported to be increased in the lung tissue of patients undergoing CLAD. This study used a novel cfDNA and CXCL10 assay to evaluate the noninvasive assessment of CLAD phenotype and prediction of survival from bronchoalveolar lavage (BAL) fluid. A total of 60 BAL samples (20 with bronchiolitis obliterans (BOS), 20 with restrictive allograft syndrome (RAS), and 20 with stable allografts (STA)) were collected from 60 unique lung transplant patients; cfDNA and CXCL10 were measured by the ELISA-based KIT assay. Median cfDNA was significantly higher in BOS patients (6739 genomic equivalents (GE)/mL) versus STA (2920 GE/mL) and RAS (4174 GE/mL) (p < 0.01 all comparisons). Likelihood ratio tests revealed a significant association of overall survival with cfDNA (p = 0.0083), CXCL10 (p = 0.0146), and the interaction of cfDNA and CXCL10 (p = 0.023) based on multivariate Cox proportional hazards regression. Dichotomizing patients based on the median cfDNA level controlled for the mean level of CXCL10 revealed an over two-fold longer median overall survival time in patients with low levels of cfDNA. The KIT assay could predict allograft survival with superior performance compared with traditional biomarkers. These data support the pursuit of larger prospective studies to evaluate the predictive performance of cfDNA and CXCL10 prior to lung allograft failure.
Keywords: cfDNA; CXCL10; lung transplantation; allograft dysfunction; CLAD; BAL cfDNA; CXCL10; lung transplantation; allograft dysfunction; CLAD; BAL

Share and Cite

MDPI and ACS Style

Yang, J.Y.C.; Verleden, S.E.; Zarinsefat, A.; Vanaudenaerde, B.M.; Vos, R.; Verleden, G.M.; Sarwal, R.D.; Sigdel, T.K.; Liberto, J.M.; Damm, I.; et al. Cell-Free DNA and CXCL10 Derived from Bronchoalveolar Lavage Predict Lung Transplant Survival. J. Clin. Med. 2019, 8, 241. https://doi.org/10.3390/jcm8020241

AMA Style

Yang JYC, Verleden SE, Zarinsefat A, Vanaudenaerde BM, Vos R, Verleden GM, Sarwal RD, Sigdel TK, Liberto JM, Damm I, et al. Cell-Free DNA and CXCL10 Derived from Bronchoalveolar Lavage Predict Lung Transplant Survival. Journal of Clinical Medicine. 2019; 8(2):241. https://doi.org/10.3390/jcm8020241

Chicago/Turabian Style

Yang, Joshua Y.C., Stijn E. Verleden, Arya Zarinsefat, Bart M. Vanaudenaerde, Robin Vos, Geert M. Verleden, Reuben D. Sarwal, Tara K. Sigdel, Juliane M. Liberto, Izabella Damm, and et al. 2019. "Cell-Free DNA and CXCL10 Derived from Bronchoalveolar Lavage Predict Lung Transplant Survival" Journal of Clinical Medicine 8, no. 2: 241. https://doi.org/10.3390/jcm8020241

APA Style

Yang, J. Y. C., Verleden, S. E., Zarinsefat, A., Vanaudenaerde, B. M., Vos, R., Verleden, G. M., Sarwal, R. D., Sigdel, T. K., Liberto, J. M., Damm, I., Watson, D., & Sarwal, M. M. (2019). Cell-Free DNA and CXCL10 Derived from Bronchoalveolar Lavage Predict Lung Transplant Survival. Journal of Clinical Medicine, 8(2), 241. https://doi.org/10.3390/jcm8020241

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop